These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors]. Szekeres L; Korom I Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488 [TBL] [Abstract][Full Text] [Related]
8. Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention. Rhodes AR Ann Intern Med; 1985 Apr; 102(4):546-8. PubMed ID: 3977199 [No Abstract] [Full Text] [Related]
9. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? Skender-Kalnenas TM; English DR; Heenan PJ J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345 [TBL] [Abstract][Full Text] [Related]
10. Risk of melanoma and other cancers in melanoma-prone families. Tucker MA; Fraser MC; Goldstein AM; Elder DE; Guerry D; Organic SM J Invest Dermatol; 1993 Mar; 100(3):350S-355S. PubMed ID: 8440923 [TBL] [Abstract][Full Text] [Related]
11. Alteration of chromosome 9p21 and/or p16 in benign and dysplastic nevi suggests a role in early melanoma progression (United States). Tran TP; Titus-Ernstoff L; Perry AE; Ernstoff MS; Newsham IF Cancer Causes Control; 2002 Sep; 13(7):675-82. PubMed ID: 12296515 [TBL] [Abstract][Full Text] [Related]
12. [Dysplastic nevus syndrome, familial predisposition toward getting melanomas]. van den Berg WH; Neering H Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1969-71. PubMed ID: 7312070 [No Abstract] [Full Text] [Related]
13. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Carey WP; Thompson CJ; Synnestvedt M; Guerry D; Halpern A; Schultz D; Elder DE Cancer; 1994 Dec; 74(12):3118-25. PubMed ID: 7982177 [TBL] [Abstract][Full Text] [Related]
14. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi. Goldstein AM; Fraser MC; Clark WH; Tucker MA J Natl Cancer Inst; 1994 Sep; 86(18):1385-90. PubMed ID: 8072031 [TBL] [Abstract][Full Text] [Related]
15. The dysplastic naevus syndrome in patients with cutaneous malignant melanoma in Western Australia. English DR; Menz J; Heenan PJ; Elder DE; Watt JD; Armstrong BK Med J Aust; 1986 Sep; 145(5):194-8. PubMed ID: 3747894 [TBL] [Abstract][Full Text] [Related]
16. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. Ackerman AB; Mihara I Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389 [No Abstract] [Full Text] [Related]
17. Dysplastic melanocytic nevi and cutaneous melanoma: markers of increased melanoma risk for affected persons and blood relatives. Albert LS; Rhodes AR; Sober AJ J Am Acad Dermatol; 1990 Jan; 22(1):69-75. PubMed ID: 2298967 [TBL] [Abstract][Full Text] [Related]
18. Multiple primary melanomas. Stam-Posthuma JJ; van Duinen C; Scheffer E; Vink J; Bergman W J Am Acad Dermatol; 2001 Jan; 44(1):22-7. PubMed ID: 11148472 [TBL] [Abstract][Full Text] [Related]
19. [Dysplastic nevus syndrome]. Kint A Z Hautkr; 1986 May; 61(9):595-8. PubMed ID: 3716535 [TBL] [Abstract][Full Text] [Related]
20. Dysplastic nevi and other risk markers for melanoma. Seykora J; Elder D Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]